Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension

Journal of Hypertension

Volumn 23, Issue 5, 2005, Pages 1025-1036

  Adeagbo, Ayotunde S O ^a   Zhang, Xiaodong ^a   Patel, Darshana ^a   Joshua, Irving G ^a   Wang, Yang ^b   Sun, Xichun ^a   Igbo, Immaculata N ^c   Oriowo, Mabayoje A ^d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c PRAIRIE VIEW A AND M UNIVERSITY   (United States)

^d KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cyclooxygenase 2; Deoxycorticosterone acetate salt induced hypertension; Endothelium; Rat aorta

Indexed keywords

ANTIOXIDANT; CYCLOOXYGENASE 2; DEOXYCORTICOSTERONE ACETATE; ISOPROSTANE DERIVATIVE; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN CHLORIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; FORCE TRANSDUCER; HYPERTENSION; MALE; MULTICHANNEL RECORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIVITY ANALYSIS; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

EID: 18344379715     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000166844.42227.5c     Document Type: Article

References (46)

1. Holloway ET, Bohr DF. Reactivity of vascular smooth muscle in hypertensive rats. Circ Res 1973; 33:678-685.
2. Mecca TE, Webb RC. Vascular responses to serotonin in steroid hypertensive rats. Hypertension 1984; 6:887-892.
3. Kanagy NL, Webb RC. Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension, Hypertension 1996; 27:740-745.
4. Rinaldi G, Bohr DF. Endothelium-mediated spontaneous response in aortic rings of deoxycorticosterone acetate hypertensive rats. Hypertension 1989; 13:256-261.
5. Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res 2002; 91:360-369.
6. Dellipizzi A, Pucci ML, Mosny AY, Deseyn K, Nasjiletti A. Contribution of constrictor prostanoids to the calcium-dependent basal tone in the aorta from rats with aortic coarctation-induced hypertension: relationship to nitric oxide. J Pharmacol Exp Ther 1997; 283:75-87.
7. White RM, Rivera CO, Davison CB. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension 1996; 27:1245-1253.
8. Ghost M, Wang HD, McNeil R. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol 2004; 141:562-573.
9. Adeagbo ASO, Patel D, Iddrissu A, Walker J, Thirumalai S, Joshua IG, et al. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium. Eur J Pharmacol 2003; 458:145-154.
10. Adeagbo ASO, Joshua IG, Falkner C, Matheson PJ. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. Eur J Pharmacol 2003; 481:91-100.
11. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 2002; 283:281-283.
12. Kastenbauer S, Koedel U, Becker BF, Pfister HW. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy. Eur J Pharmacol 2002; 449:177-181.
13. Zewde T, Mattson DL. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension 2004; 44:424-428.
14. Zimmerman KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59:198-204.
15. 2α, in rabbit lung in situ. Am J Physiol Heart Circ Physiol 1992; 263:H660-H663.
16. Krysztopik RJ, Matheson PJ, Spain DA, Garrison RN, Wilson MA. Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 2000; 93:75-81.
17. Uderman HD, Jackson EK, Puett D, Workman RJ. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in adult spontaneously hypertensive rat. J Cardiovasc Pharmacol 1984; 6:969-972.
18. Lariviere R, Day R, Schiffrin EL, Increased endothelial gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993; 21:916-925.
19. Cryer B, Dubois A. The advent of highly selective inhibitors of cyclooxygenase - a review. Prostaglandins Other Lipid Mediators 1998; 56:341-361.
20. Garcia-Cohen EC, Martin J, Diez-Picazo LD, Baena AB, Salaices M, Rodriguez-Martinez MA. Oxidative stress induced by tert-buty hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J Pharmacol Exp Ther 2000; 293:75-81.
21. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-induced cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11:371-386.
22. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN. Cyclooxygenase-2 is associated with the densa of rat kidney and increases with salt restriction. J Clin Invest 1994; 94:2504-2510.
23. Vio CP, Cespedes C, Gallardo P, Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 1997; 30:687-692.
24. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 1995; 76:1003-1010.
25. Zerrouk A, Auguet M, Chabrier PE. Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta; role of an inducible cyclooxygenase metabolite. J Cardiovasc Pharmacol 1998; 31:525-533.
26. Tomida T, Numaguchi Y, Nishimoto Y, Tsuzuki M, Hayashi Y, Imai H, et al. Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2α formation in L-NAME-treated rats. J Hypertens 2003; 21:601-609.
27. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 1990; 15:699-703.
28. Auch-Schwelk W, Vanhoutte PM. Endothelium-derived contracting factor released by serotonin in the aorta of the SHR. Am J Hypertens 1991; 4:769-772.
29. Auch-Schwelk W, Vanhoutte PM. Contractions to endothelin in normotensive and spontaneously hypertensive rats: role of endothelium and prostaglandins. Blood Press 1992; 1:45-49.
30. O'Donnell VB. Free radicals and lipid signaling in endothelial cells. Antioxid Redox Signal 2003; 5:195-203.
31. 2α in rat aortic rings. Prostaglandins 1997; 54:581-599.
32. 2α: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998; 58:319-325.
33. 2α. Br J Pharmacol 2001; 133:643-650.
34. Maffei Facino R, Carini M, Aldini G. Antioxidant activity of nimesulide and its main metabolites. Drugs 1993; 46:15-21.
35. Bevilacqua M, Vago T, Saldi G, Renesto E, Dallegri F, Norbiato G. Nimesulide decreases Superoxide production by inhibiting phosphodiesterase type IV. Eur J Pharmacol 1994; 268:415-423.
36. Mouithys-Mickalad AM, Zheng SX, Deby-Dupont GP, Deby CM, Lamy MM, Reginster JY, Hendrotin YE. In vitro study of the antioxidant properties of nonsteroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic Res Commun 2000; 33:607-621.
37. Grosser N, Schroder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide cGMP pathway. Arterioscler Thromb Vasc Biol 2003; 23:1345-1351.
38. Zhao H, Joshua IG, Porter JP. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 2000; 13:819-826.
39. A-NADPH oxidase pathway in low renin hypertension. Hypertension 2003; 107:1053-1058.
40. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T, et al. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Res 1992; 20:11-S14.
41. Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension 1993; 21:9-15.
42. Zerrouk A, Champeroux P, Safar M, Brisac AM. Role of endothelium in the endothelin-1 -mediated potentiation of the norepinephrine response in the aorta of hypertensive rats. J Hypertens 1997; 15:1101-1111.
43. Sugimoto T, Haneda M, Sawano H, Isshiki K, Maeda S, Koya D, et al. Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells. J Am Soc Nephrol 2001; 12:1359-1368.
44. Chen D, Balyakina EV, Lawrence M, Christman BW, Meyrick B. Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003; 2841614-L621.
45. Zhang M-Z, Hao C-M, Breyer MD, Harris RC, McKanna JA. Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla. Am J Physiol Renal Physiol 2002; 283:F509-F516.
46. Virdls A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002; 40:504-510.